Affiliation:
1. Neurology Service, Hyogo Brain and Heart Center, Himeji, Japan.
Abstract
Intracarotid urokinase infusion therapy was performed on 22 patients with evolving cerebral infarction due to acute thromboembolic occlusion of the middle cerebral artery. Mean time from onset of symptoms to start of infusion and mean dosage of urokinase were 4.5 hours and 927,000 units, respectively. Immediate recanalization was achieved in 10 patients (45%) after urokinase therapy. In patients with successful recanalization, rapid amelioration of symptoms followed the restoration of blood flow. Thrombolytic recanalization was associated with reduction of neurologic deficits and of computed tomography-demonstrable infarction volume. The reduction of infarction volume and functional outcome correlated highly with the degree of reflow. Hemorrhagic transformation of infarction occurred in four patients and controllable extracranial bleeding in three patients. These results support the safety and efficacy of urokinase therapy for acute thromboembolic occlusion of the middle cerebral artery.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology
Reference51 articles.
1. Treatment of cerebrovascular thrombosis with fibrinolysin preliminary report∗
2. The treatment of cerebrovascular thromboses and embolism with fibrinolytic agents
3. Meyer JS Herndon RM Gotoh F Tazaki Y Nelson JN Johnson JF: Therapeutic thrombolysis in Millikan CH Siekert RG WhisnantJP (eds): Cerebral Vascular Disease Third Princeton Conference. New York Grune & Stratton 1961 pp 160-177
4. Meyer JS Gilroy J Bernhart ME Johnson JF: Therapeutic thrombolysis in cerebral thromboembolism: Randomized evaluation of intravenous streptokinase in Millikan CH Siekert RG WhisnantJP (eds): Cerebral Vascular Diseases Fourth Princeton Conference. New York Grune & Stratton 1965 pp 200-213
Cited by
339 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献